What is the role of the anti-tissue transglutaminase (anti-tTG) Immunoglobulin A (IgA) test in diagnosing coeliac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Role of Anti-tTG IgA Test in Diagnosing Coeliac Disease

The IgA anti-tissue transglutaminase (tTG-IgA) test is the preferred initial screening test for coeliac disease due to its high sensitivity (90-96%) and specificity (>95%), and should be performed while the patient is on a gluten-containing diet. 1

Initial Diagnostic Testing

  • tTG-IgA is the most efficient single serologic test for detecting coeliac disease in the primary care setting 2
  • Testing must be performed while the patient is on a gluten-containing diet (at least 10g daily for 6-8 weeks) to avoid false negative results 1
  • The test has excellent sensitivity (90-96%) and specificity (>95%), making it superior to older gliadin antibody testing 2, 1
  • Total IgA levels should be measured when there is suspicion of IgA deficiency, as this could lead to false negative results 1, 3

Confirmatory Testing

  • Positive serologic results should be followed by intestinal biopsy, which remains the gold standard for diagnosis 2
  • Multiple duodenal biopsy specimens (ideally 6) should be taken from the second part of the duodenum or beyond 2, 1
  • Characteristic histologic findings include villous atrophy, crypt lengthening, and increased intraepithelial lymphocytes 2, 1
  • In patients with tTG-IgA levels >10x upper limit of normal, IgA endomysial antibody (EMA-IgA) should be performed as a confirmatory test due to its excellent specificity (99.6%) 1, 3

Special Testing Considerations

  • In IgA-deficient patients, IgG-based tests should be used instead:
    • IgG endomysial antibody (EMA-IgG) 2, 4
    • IgG deamidated gliadin peptide (DGP-IgG) 1
    • IgG tissue transglutaminase (tTG-IgG) 1, 4
  • IgG anti-tTG testing has limited utility when tTG-IgA is negative in patients with normal IgA levels 5
  • The combination of tTG-IgA and EMA-IgA has a positive predictive value approaching 97% 6
  • HLA-DQ2 and HLA-DQ8 testing has high negative predictive value and is useful when coeliac disease is strongly suspected despite negative serology 1, 7

High-Risk Groups to Consider Testing

  • First-degree relatives of patients with coeliac disease 1, 7
  • Patients with type 1 diabetes mellitus 1, 7
  • Patients with unexplained iron deficiency anemia 1, 7
  • Patients with premature osteoporosis 1, 7
  • Patients with autoimmune thyroid disease 1
  • Patients with unexplained liver transaminase elevations 1, 7
  • Patients with Down syndrome 1, 7

Common Pitfalls in Diagnosis

  • Initiating a gluten-free diet before completing diagnostic testing can lead to false-negative results 1, 3
  • Relying solely on serology without biopsy confirmation can lead to misdiagnosis 2, 1
  • IgG isotype testing for tTG antibody has limited utility in the absence of IgA deficiency 5
  • Antigliadin antibody testing is outdated and should not be used as the primary test due to inferior diagnostic performance 2
  • In children under 2 years, tTG-IgA testing should be combined with IgG and IgA deamidated gliadin peptides for improved sensitivity 2, 7

Monitoring After Diagnosis

  • Follow-up serology should be performed at 6 and 12 months after diagnosis, and yearly thereafter 1
  • Negative serology after treatment does not guarantee intestinal mucosal healing 1
  • Persistently positive serology usually indicates ongoing intestinal damage and continued gluten exposure 1, 3

References

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.

Journal of pediatric gastroenterology and nutrition, 2017

Guideline

Celiac Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.